How have ABVC and NSPR total returns compared?

Over the past 10 years, ABVC delivered -44.60% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

ABVC BioPharma, Inc. (ABVC) vs InspireMD, Inc. (NSPR)

A side-by-side comparison of ABVC BioPharma, Inc. and InspireMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABVC

ABVC BioPharma, Inc.

$25M

$0.95HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

NSPR

InspireMD, Inc.

$27M

$0.57HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

Total return — ABVC vs NSPR

growth of $100 · dividends reinvested · last 10y

ABVC -99.7% (-44.6%/yr)NSPR -100.0% (-68.2%/yr)ABVC compounded faster over this window

Log scale — wide-divergence pair

ABVC NSPR

ABVC vs NSPR: by the numbers

•NSPR is the larger company ($27M vs $25M market cap).
•Both run net losses; ABVC's is the smaller (0.00% vs -355.17% net margin).

Metrics side by side

Valuation

Metric	ABVC	NSPR
P/S ratio	N/A	2.45
P/B ratio	2.40	0.84

Profitability

Metric	ABVC	NSPR
Gross margin	0.00%	29.50%
Operating margin	0.00%	-546.97%
Net margin	0.00%	-355.17%
ROE	-76.82%	-122.19%
ROIC	-53.34%	-153.04%

Growth (annualized)

Metric	ABVC	NSPR
Revenue CAGR (5Y)	N/A	27.79%
Total return CAGR (5Y)	-46.33%	-36.91%

Frequently asked

How have ABVC and NSPR total returns compared?: Over the past 10 years, ABVC delivered -44.60% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABVC analysis Full NSPR analysis Interactive comparison tool

Dig into the metrics

ABVC BioPharma ROE InspireMD ROE ABVC BioPharma operating margin InspireMD operating margin ABVC BioPharma revenue growth InspireMD revenue growth ABVC BioPharma free cash flow InspireMD free cash flow

ABVC BioPharma & InspireMD appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.